PE Ratio P/S Ratio P/B Ratio Price-FCF Ratio Market Cap
Current and historical daily P/E ratio for ABBV (AbbVie Inc) from 2012 to Sep 28 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. AbbVie stock (ABBV) PE ratio as of Sep 28 2020 is 18.57. More Details

AbbVie PE Ratio (TTM) Chart

EMBED

AbbVie PE Ratio (TTM) Historical Data

Total 1304
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
AbbVie PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2020-09-2818.6 2020-07-2720.7
2020-09-2518.4 2020-07-2420.7
2020-09-2418.3 2020-07-2320.9
2020-09-2318.5 2020-07-2220.8
2020-09-2218.9 2020-07-2120.7
2020-09-2119.0 2020-07-2021.2
2020-09-1819.2 2020-07-1721.5
2020-09-1719.1 2020-07-1621.3
2020-09-1619.1 2020-07-1521.4
2020-09-1519.3 2020-07-1421.0
2020-09-1419.3 2020-07-1320.8
2020-09-1119.1 2020-07-1020.6
2020-09-1019.1 2020-07-0920.8
2020-09-0919.5 2020-07-0821.1
2020-09-0819.2 2020-07-0721.1
2020-09-0719.6 2020-07-0621.1
2020-09-0419.6 2020-07-0321.0
2020-09-0319.6 2020-07-0221.0
2020-09-0220.0 2020-07-0121.1
2020-09-0119.6 2020-06-3020.9
2020-08-3120.4 2020-06-2920.5
2020-08-2820.0 2020-06-2617.0
2020-08-2720.1 2020-06-2517.2
2020-08-2620.1 2020-06-2416.8
2020-08-2520.0 2020-06-2317.2
2020-08-2420.1 2020-06-2217.2
2020-08-2120.2 2020-06-1917.1
2020-08-2020.3 2020-06-1817.0
2020-08-1920.5 2020-06-1717.0
2020-08-1820.4 2020-06-1617.0
2020-08-1720.5 2020-06-1516.5
2020-08-1420.2 2020-06-1216.4
2020-08-1320.1 2020-06-1116.3
2020-08-1220.3 2020-06-1017.2
2020-08-1119.7 2020-06-0917.0
2020-08-1019.7 2020-06-0816.7
2020-08-0719.8 2020-06-0516.6
2020-08-0619.7 2020-06-0416.5
2020-08-0519.8 2020-06-0316.1
2020-08-0420.1 2020-06-0216.1
2020-08-0320.4 2020-06-0116.1
2020-07-3120.2 2020-05-2916.4
2020-07-3020.4 2020-05-2815.9
2020-07-2920.6 2020-05-2715.9
2020-07-2820.6 2020-05-2616.1

AbbVie PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Industry Healthcare » Drug Manufacturers » NAICS : 325412 NAICS : 5122
Address 1 North Waukegan Road, North Chicago, IL, USA, 60064-6400
AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013. The recent announced acquisition of Allergan will add several new drugs in aesthetics and women's health.